Haemophilus influenzae

Alpha-hydroxyisobutyric acid is an organic acid metabolite of the gasoline additive methyl tertiary-butyl ether (MTBE) and a human xenobiotic metabolite.  Elevated levels of Alpha-hydroxyisobutyric acid in urine have been associated with obesity, hepatic steatosis, and potential links to metabolic disorders.   

Despite being phased out in the early 2000s, MTBE continues to pose a risk of environmental exposure due to its persistence in soil, groundwater, and ambient air.   

Alpha-hydroxyisobutyric acid serves as a synthetic precursor for 2-hydroxyisobutyryl coenzyme A, which is crucial for lysine 2-hydroxyisobutyrylation (Khib), a novel post-translational modification that impacts protein function and is increasingly linked to metabolic pathways and metabolic disease due to MTBE exposure.  

This article explores the role of Alpha-hydroxyisobutyric acid as a marker for MTBE exposure and its role in the development of disease, as well as discusses testing options to assess an individual’s exposure to MTBE by assessing levels of the organic acid Alpha-hydroxyisobutyric acid.  

What Are Organic Acids?  [4., 5.]

Organic acids are organic compounds with acidic properties.  They include a variety of functional groups like carboxyl, phenol, enol, and thiol, with carboxylic acids having the strongest acidity.

Organic acids are considered weak acids, with those containing phenol, enol, alcohol, or thiol groups being even weaker.  

Their structures vary in terms of carbon chain types—aromatic, aliphatic, alicyclic, heterocyclic—saturation, substitutions, and the number of functional groups. 

These acids play critical roles in metabolic and catabolic pathways, notably in the tricarboxylic acid cycle inside mitochondria, which is central to energy production in eukaryotes.  They are also pivotal in determining the sensory properties of fruits and vegetables.

Organic Acid Disorders  [2., 16.]

Organic acid disorders are inherited metabolic conditions that affect the enzymes or transport proteins essential for the breakdown of amino acids, lipids, or carbohydrates. They are marked by the excessive excretion of non-amino organic acids in urine, primarily due to defects in specific enzymes involved in amino acid breakdown that cause buildup of organic acids in tissues.

Conditions can manifest as inborn metabolic disorders of organic acids and amino acids, urea cycle anomalies, and mitochondrial respiratory chain deficiencies.

These disorders are typically passed down through autosomal recessive inheritance.  They often present in newborns with symptoms like vomiting and lethargy, progressing to more severe neurological symptoms. 

Early diagnosis and intervention are critical and can improve outcomes. Diagnostic methods include urine organic acid analysis via gas chromatography-mass spectrometry (GC/MS). 

Current treatments focus on managing symptoms and preventing complications, although definitive therapies are still under research.  Treatment focuses may include dietary management, detoxifying harmful metabolites, and in severe cases, organ transplantation. 

Continuous monitoring and management are essential for managing symptoms and preventing complications.

Organic Acids and the Microbiome  [8.]

Increasingly, research highlights new relationships between the microbiome and human health.  Many organisms that comprise the microbiome produce organic acids that can then be tested for additional diagnostic capability.  

Certain organic acids in urine like hippuric acid, benzoic acid, and indoleacetic acid are metabolites produced by gut bacteria from the breakdown of amino acids, dietary polyphenols, and other substances. 

These acids provide insights into gut health and metabolic functions.  For example, elevated levels of certain acids may indicate gut dysbiosis or specific metabolic imbalances, such as phenylketonuria. 

Some organic acids known to be produced by the microbiome include: 

Benzoic Acid (BA): 

Produced from phenylalanine and polyphenol metabolism by intestinal bacteria. High levels in urine can indicate glycine deficiency or liver dysfunction.

Hippuric Acid (HA):

Formed in the liver by conjugation of benzoic acid with glycine. Elevated levels may indicate exposure to environmental toxins like toluene.

Phenylacetic Acid (PAA) and Phenylpropionic Acid (PPA): 

These acids result from phenylalanine metabolism by gut bacteria. High urinary levels can suggest dysbiosis or disorders like phenylketonuria. PAA is also associated with depression markers.

4-Hydroxybenzoic Acid (4-HBA) and 4-Hydroxyphenylacetic Acid (4-HPAA): 

Derivatives of tyrosine metabolism. 4-HBA is linked to catechin (green tea) metabolism, and 4-HPAA is useful in diagnosing small bowel diseases related to bacterial overgrowth.

3-Hydroxyphenylpropionic Acid (3-HPPA): 

A metabolite from dietary polyphenols like proanthocyanidins, indicative of robust bacterial metabolism in the intestines.

3,4-Dihydroxyphenyl Propionic Acid (3,4-DHPPA): 

Produced from dietary quinolones by clostridial species, with high levels suggesting an overgrowth.

3-Indoleacetic Acid (IAA): A breakdown product of tryptophan by gut bacteria such as Bifidobacterium and Bacteroides. Elevated levels are seen in conditions like phenylketonuria or dietary changes.

These organic acids are important markers in clinical diagnostics, helping to monitor metabolic disturbances, gut microbiota balance, and exposure to environmental toxins.

Their presence and concentration are influenced by diet, gut microbiota composition, and overall metabolic health, making them valuable indicators in clinical settings for assessing both metabolic and gastrointestinal conditions.

What is Alpha-hydroxyisobutyric acid?  [10., 11.]

Alpha-hydroxyisobutyric acid (Alpha-hydroxyisobutyric acid) is a metabolic byproduct of the gasoline additive methyl tertiary-butyl ether (MTBE) and a human xenobiotic metabolite.  

Elevated levels of Alpha-hydroxyisobutyric acid in urine have been associated with obesity and hepatic steatosis, indicating a potential link to metabolic disorders. Its microbial origin in humans remains speculative.

Exposure Sources of MTBE, the Parent Compound of Alpha-hydroxyisobutyric acid  [BENSON>>>

Alpha-hydroxyisobutyric acid is a metabolite of the gasoline additive methyl tertiary-butyl ether (MTBE).  

Alpha-hydroxyisobutyric acid is a primary urinary metabolite of methyl tert-butyl ether (MTBE), an industrial solvent previously used as a gasoline additive to lower vehicle emissions.  

Despite being phased out in the early 2000s, MTBE continues to pose a risk of environmental exposure due to its persistence in soil, groundwater, and ambient air.  Urine levels of 2-Hydroxybutyric acid are an indicator of recent MTBE exposure.  [1.]

Originally classified as non-carcinogenic, MTBE is now under scrutiny for potential health risks. Recent research links MTBE exposure to type 2 diabetes through disruptions in zinc homeostasis and glucose tolerance. It is also associated with clinical conditions such as autism, DNA oxidative damage, and methylation defects.

However, studies exploring its effects on cancer, reproductive health, nonalcoholic fatty liver disease, and neurotoxicity have yielded either negative or inconclusive results.

Health Effects of Alpha-hydroxyisobutyric acid  [9., 10.]

Alpha-hydroxyisobutyric acid has been associated with metabolic diseases such as diabetes and obesity, as well as autism and other clinical conditions. 

It serves as a synthetic precursor for 2-hydroxyisobutyryl coenzyme A, which is regulated by carbon sources. This compound is crucial for lysine 2-hydroxyisobutyrylation (Khib), a novel post-translational modification that impacts protein function significantly by modifying lysine residues.  

This modification process, first identified in histones, has been observed to enhance transactivation in mammals and is increasingly linked to metabolic pathways, including glycolysis and the tricarboxylic acid cycle. 

The role of Alpha-hydroxyisobutyric acid in promoting Khib suggests its potential involvement in metabolic disorders and cancer progression, making it a target for further biochemical research and therapeutic interventions.

Lysine 2-Hydroxyisobutyrylation  [9.]

Lysine 2-hydroxyisobutyrylation (Khib) is a newly recognized type of post-translational modification (PTM) that was initially discovered in histones and acts as a regulator of transcription in mammals. Its broader implications are still under exploration. 

In a study involving patients with pancreatic cancer, a comprehensive analysis using liquid chromatography-tandem mass spectrometry (LC-MS/MS) identified 10,367 Khib sites across 2,325 proteins, including 27 sites on histones.  [9.]

These Khib-modified proteins are significantly involved in metabolic pathways such as glycolysis, the tricarboxylic acid cycle, and fatty acid degradation.  The study also found that Khib overlaps with other PTMs like succinylation and acetylation, suggesting a complex interplay among these modifications.

In addition, the study highlighted the potential of MG149, a Tip60 inhibitor, to significantly reduce Khib modification levels in pancreatic cancer cells, resulting in decreased cell proliferation, migration, and invasion.  

Alpha-hydroxyisobutyric acid and Cardiometabolic Health  [14.]

Elevated levels of Alpha-hydroxyisobutyric acid found in individuals with obesity and hepatic steatosis suggest its potential involvement in metabolic health.  

Global studies indicate a rising prevalence of type 2 diabetes linked to environmental pollutants, including methyl tert-butyl ether (MTBE). 

This gasoline additive, which is associated with elevated 2-hydroxybutyric acid levels in humans, is suspected of disrupting zinc and glucose homeostasis. 

In a study involving male Sprague–Dawley rats, MTBE was administered in drinking water for 90 days.  Post-treatment assessments of pancreatic and blood samples, including gene expression analyses and biochemical markers such as fasting blood glucose and lipid profiles, revealed that MTBE exposure might interfere with zinc regulation and glucose tolerance, highlighting potential metabolic disruptions.  [14.]

MTBE Exposure, 2-Hydroxybutyric Acid and Autism  [7.]

Exposure to methyl tert-butyl ether (MTBE) and its metabolite, Alpha-hydroxyisobutyric acid, has been implicated in the development of autism spectrum disorder (ASD) through studies examining environmental toxins. 

Research investigating perinatal exposure to various air toxics, including MTBE, suggests a potential link with ASD.  Specifically, MTBE, a former gasoline additive, is associated with ASD risk when present in the ambient air at significant levels, indicating a possible ongoing environmental health concern. 

Additional Health Effects of Exposure to MTBE and Alpha-hydroxyisobutyric acid Levels

Methyl tertiary-butyl ether (MTBE) has potential immunotoxic effects, particularly on human blood lymphocytes.  [15.]

Studies have shown that MTBE exposure can lead to decreased cell viability and significant increases in reactive oxygen species (ROS), lipid peroxidation, and damage to mitochondria and lysosomes in these cells.  [15.]

The cytotoxic effects were notable even at low concentrations that are typical in human blood due to occupational and environmental exposure.

Additional research on petrol station workers has indicated that exposure to MTBE, along with benzene, affects DNA by altering the expression and methylation of DNA repetitive elements, which could potentially impact gene regulation and stability.  [12.]

Alpha-hydroxyisobutyric acid and Alcohol Intake  [6.]

Metabolomics studies of acute alcohol consumption, using GC-MS profiling of organic acids, have provided insights into the metabolic impact of a single binge drinking event in healthy, moderate-drinking young men. 

This approach revealed disturbances in several metabolic pathways, such as glycolysis, ketogenesis, the Krebs cycle, and gluconeogenesis, due to the altered NADH:NAD+ ratio in hepatocytes. 

Notably, the presence of Alpha-hydroxyisobutyric acid was significant, supporting its role as a key endogenous metabolite with increased alcohol consumption. 

This study also highlights 2-hydroxyisobutyrylation as a potential novel regulatory mechanism in histone modification, opening new avenues for understanding the metabolic and epigenetic effects of alcohol consumption.

Organic Acid Testing in Functional Medicine

Organic Acid Testing in Functional Medicine

In functional medicine, organic acid testing is utilized to evaluate a patient's metabolic function through a simple urine test. This testing can identify metabolic imbalances that may affect a patient’s mood, energy, and overall health. 

Testing provides insights into nutrient deficiencies, dietary habits, toxic exposures, and gut microbiome activity. 

The results assist practitioners in customizing treatment plans to address specific metabolic dysfunctions and improve health outcomes. 

Additionally, it helps in assessing the impact of microbial metabolism and the efficiency of the Krebs Cycle, aiding in personalized healthcare.

Lab Testing for Alpha-hydroxyisobutyric acid

Test Information, Sampling Methods and Preparation

Laboratory testing for organic acids including Alpha-hydroxyisobutyric acid is typically done in urine, although it can also be tested in blood.  Testing may be ordered to diagnose an inborn metabolic disorder, or to assess metabolic function and gastrointestinal health in a functional medicine setting.  

Urine samples may be collected in a clinical setting; they can also be collected at home.  Some labs recommend or require a first morning void sample, to provide a concentrated sample.  

Interpreting Alpha-hydroxyisobutyric acid Results

Optimal Range for Alpha-hydroxyisobutyric acid Testing

Generally, falling within reference ranges for organic acids is recommended, although for many of these organic acids, a level towards the lower end of the reference range is considered optimal.  

It is essential to consult with the laboratory company used for their recommended reference range for Alpha-hydroxyisobutyric acid.  

Clinical Significance of Elevated Levels of Alpha-hydroxyisobutyric acid

Elevated levels of Alpha-hydroxyisobutyric acid are commonly associated with several clinical conditions that involve metabolic stress and insulin resistance.  

One of the primary conditions linked with high 2-hydroxybutyric acid levels is Type 2 Diabetes Mellitus (T2D), where it serves as an indicator of impaired glucose metabolism and insulin sensitivity.  In T2D, insulin resistance leads to altered lipid and carbohydrate metabolism, contributing to increased oxidative stress and subsequent production of 2-hydroxybutyric acid. 

Additionally, high levels of 2-hydroxybutyric acid are noted in conditions characterized by severe metabolic disturbances including lactic acidosis and ketoacidosis.  

These conditions often occur in severe diabetic states or in response to extreme physical stress such as prolonged fasting or intense exercise, where the body relies heavily on lipolysis and amino acid catabolism for energy, leading to an accumulation of organic acids including 2-hydroxybutyric acid. 

Monitoring 2-hydroxybutyric acid levels can provide valuable insights into the metabolic status of patients and help in the early detection and management of metabolic complications related to insulin resistance and other stress-related metabolic states.

Clinical Significance of Low Levels of 2-Hydroxybutyric Acid

Low levels of 2-hydroxybutyric acid are not considered clinically relevant.  

Alpha-hydroxyisobutyric acid Related Biomarkers and Comparative Analysis

Alpha-hydroxyisobutyric acid is typically tested along with other organic acids to gain deeper insights into metabolic pathways and physiological processes.

Organic acids that may be tested as part of a panel include: 

2-Hydroxybutyric Acid: this acid is a marker for insulin resistance and increased oxidative stress.

2-Hydroxyphenylacetic Acid: derived from phenylalanine metabolism, this acid is used as a biomarker in various metabolic assessments.

3-Hydroxybutyric Acid: a ketone body produced during fat metabolism, indicative of carbohydrate deprivation or ketogenic conditions.

3-Hydroxyisovaleric Acid: an organic acid that accumulates in leucine catabolism disorders, often elevated in maple syrup urine disease.

‍3-Indoleacetic Acid: a metabolite of tryptophan, it is significant in the study of serotonin pathways and plant growth regulation.

‍4-Hydroxybenzoic Acid: a derivative of tyrosine metabolism, it is linked to catechin (green tea) metabolism and may be produced by some intestinal bacteria.

4-Hydroxyphenyllactic Acid: a metabolite associated with disorders of tyrosine metabolism.

4-Hydroxyphenylacetic Acid: a breakdown product of tyrosine, used in diagnosing disorders involving the degradation of aromatic amino acids.

5-Hydroxyindoleacetic Acid: the main metabolite of serotonin, used as a marker in the diagnosis of carcinoid syndrome.

Adipic Acid: a dicarboxylic acid that can also be formed metabolically in humans through the oxidation of certain fatty acids.

a-Keto-b-Methylvaleric Acid: an intermediate in isoleucine metabolism, which can accumulate in certain metabolic disorders.

a-Ketoisocaproic Acid: an intermediate in the metabolism of leucine, elevated in maple syrup urine disease.

a-Ketoisovaleric Acid: a breakdown product of valine metabolism, also linked to maple syrup urine disease.

a-Ketoglutaric Acid: a key intermediate in the citric acid cycle, essential for energy production and nitrogen transport.

Benzoic Acid: produced from phenylalanine and polyphenol metabolism by intestinal bacteria. High levels in urine can indicate glycine deficiency or liver dysfunction.

Cis-Aconitic Acid: an intermediate in the tricarboxylic acid cycle, formed by the dehydration of citric acid.

Citric Acid: a central compound in the citric acid cycle, crucial for energy production in cells.

Ethylmalonic Acid: this acid accumulates in ethylmalonic encephalopathy and is involved in fatty acid metabolism.

Fumaric Acid: an intermediate in the tricarboxylic acid (TCA) cycle, participating in energy production through its conversion to malate and subsequent participation in the generation of ATP.

Homovanillic Acid: a major metabolite of dopamine, used as a marker to monitor dopamine levels.

‍Hippuric Acid: formed from the conjugation of benzoic acid and glycine; elevated levels can indicate exposure to certain environmental toxins.

Hydroxymethylglutarate: an intermediate in leucine metabolism, also associated with disorders of ketogenesis and ketolysis.

Isocitric Acid: an isomer of citric acid and an important part of the citric acid cycle, pivotal in cellular energy production.

Kynurenic Acid: a product of tryptophan metabolism, known for its role as a neuroprotective agent.

Lactic Acid: produced from pyruvate via anaerobic metabolism, an indicator of hypoxia and strenuous exercise.

Malic Acid: a dicarboxylic acid found in fruits, and involved  in the citric acid cycle.

Methylmalonic Acid: an indicator of Vitamin B12 deficiency, it accumulates when the vitamin is deficient.

Methylsuccinic Acid: a dicarboxylic acid often involved in alternative pathways of fatty acid metabolism.

Orotic Acid: involved in the metabolism of pyrimidines, abnormalities in its levels can indicate metabolic disorders.

Pyroglutamic Acid: an uncommon amino acid derivative that can accumulate in glutathione synthesis disorders.

Pyruvic Acid: a key intersection in several metabolic pathways; its levels are crucial for assessing cellular respiration and metabolic function.

Quinolinic Acid: a neuroactive metabolite of the kynurenine pathway, elevated levels are associated with neurodegenerative diseases.

Suberic Acid: a dicarboxylic acid that is a biomarker in adipic aciduria, often studied in relation to fatty acid oxidation disorders.

Succinic Acid: a four-carbon dicarboxylic acid that plays a central role in the Krebs cycle, crucial for energy production.

‍Tricarballylic Acid: an organic acid that can inhibit aconitase in the citric acid cycle and is sometimes associated with glyphosate exposure.

Vanillylmandelic Acid: a metabolite of epinephrine and norepinephrine, used as a marker for neuroblastoma and other catecholamine-secreting tumors.

Order Organic Acids Testing

Click here to compare testing options and order organic acid testing.